Regeneration Technologies' bone fillers:
This article was originally published in Clinica
Executive Summary
Regeneration Technologies has received US FDA 510(k) clearance to market its Sterling line of xenograft chips and cubes for filling in bony voids or gaps in the skeletal system, which can arise following surgery or traumatic injury. The products provide a scaffold for bone healing and become incorporated into the patient's own bone. They are rendered biocompatible and sterile using the company's patented BioCleanse tissue sterilisation process. The fillers should be available for distribution in late 2005, said the Alachua, Florida firm, which also makes implants for use in cardiovascular and other surgeries.